We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNR icon
101
RenaissanceRe
RNR
$13.6B
$2M 0.46%
6,300
+2,100
+50% +$631K
FSLR icon
102
First Solar
FSLR
$20.5B
$1.98M 0.46%
8,400
-2,100
-20% -$492K
ASO icon
103
Academy Sports + Outdoors
ASO
$3.1B
$1.98M 0.46%
+42,000
New +$2.23M
SLB icon
104
SLB Ltd
SLB
$77.6B
$1.95M 0.45%
42,000
RMBS icon
105
Rambus
RMBS
$8.83B
$1.95M 0.45%
+14,700
New +$1.91M
ASTH icon
106
Astrana Health
ASTH
$1.87B
$1.95M 0.45%
42,000
-21,000
-33% -$756K
CL icon
107
Colgate-Palmolive
CL
$69.4B
$1.93M 0.44%
21,000
PAGS icon
108
PagSeguro Digital
PAGS
$2.61B
$1.9M 0.44%
210,000
CRUS icon
109
Cirrus Logic
CRUS
$5.91B
$1.87M 0.43%
12,600
-8,400
-40% -$1.37M
POST icon
110
Post Holdings
POST
$3.56B
$1.85M 0.43%
21,000
+14,700
+233% +$1.43M
SMCI icon
111
Super Micro Computer
SMCI
$24.2B
$1.85M 0.43%
+63,000
New +$2.01M
SNDX icon
112
Syndax Pharmaceuticals
SNDX
$1.54B
$1.84M 0.42%
+84,000
New +$1.75M
STT icon
113
State Street
STT
$50.2B
$1.78M 0.41%
10,500
CMRE icon
114
Costamare
CMRE
$1.82B
$1.77M 0.41%
+126,000
New +$2.07M
PARR icon
115
Par Pacific Holdings
PARR
$4.25B
$1.77M 0.41%
31,500
-10,500
-25% -$625K
YOU icon
116
Clear Secure
YOU
$4.19B
$1.76M 0.4%
31,500
-21,000
-40% -$1.15M
ARWR icon
117
Arrowhead Research
ARWR
$9.29B
$1.71M 0.39%
+21,000
New +$1.55M
EXPD icon
118
Expeditors International
EXPD
$24.6B
$1.71M 0.39%
10,500
KO icon
119
Coca-Cola
KO
$378B
$1.71M 0.39%
21,000
REYN icon
120
Reynolds Consumer Products
REYN
$4.73B
$1.69M 0.39%
63,000
-21,000
-25% -$468K
FOR icon
121
Forestar Group
FOR
$1.35B
$1.66M 0.38%
52,500
+10,500
+25% +$289K
CUBI icon
122
Customers Bancorp
CUBI
$2.64B
$1.66M 0.38%
+21,000
New +$1.59M
HASI icon
123
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
$1.64M 0.38%
+42,000
New +$1.68M
RNG icon
124
RingCentral
RNG
$6.14B
$1.64M 0.38%
+42,000
New +$1.7M
FTDR icon
125
Frontdoor
FTDR
$5.55B
$1.63M 0.38%
21,000
-10,500
-33% -$672K

Similar funds

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.